We are live on ! Find out more
NVAX icon

Novavax

77 hedge funds and large institutions have $27M invested in Novavax in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more call options, than puts

Call options by funds: $11.5M | Put options by funds: $5.67M

4% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 23

4.65% less ownership

Funds ownership: 29.62%24.97% (-4.7%)

5% less funds holding

Funds holding: 8177 (-4)

20% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 20

24% less capital invested

Capital invested by funds: $35.7M → $27M (-$8.67M)

Holders
77
Holders Change
-4
Holders Change %
-4.94%
% of All Funds
1.52%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
22
Reduced
23
Closed
20
Calls
$11.5M
Puts
$5.67M
Net Calls
+$5.86M
Net Calls Change
-$2.65M

NVAX Hedge Fund Activity: Q4 2019 in Review

77 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q4 2019, worth a combined $27M — down 24% from $35.7M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of NVAX and 16 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 22 added.

The largest buyer was D.E. Shaw & Co, adding an estimated $732K. The largest seller was Morgan Stanley, cutting an estimated $1.58M.

  • 77 institutional investors held Novavax (NVAX) as of Q4 2019, down from 81 in Q3 2019.
  • Funds reported $27M of Novavax stock for Q4 2019, down 24% quarter-over-quarter.
  • 16 funds opened new Novavax positions in Q4 2019 and 20 closed out, a net change of -4 holders.
  • The largest Novavax buyer in Q4 2019 was D.E. Shaw & Co, an estimated $732K added.
  • The largest Novavax seller in Q4 2019 was Morgan Stanley, an estimated $1.58M sold.

Based on aggregated 13F filings for Q4 2019.